- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
- Video and telephone consultations
Luke Moore is an Infectious Diseases Physician, Microbiologist & Virologist in London with special interests in critical care infections, antimicrobial resistance, COVID-19, and healthcare systems. He holds a PhD in this field, two Masters degrees in Public Health and in Clinical Microbiology, and is Fellow of the Royal College of Pathologists and Member of the Royal College of Physicians. He is an honorary Clinical Senior Lecturer at Imperial College London, with current a research focus on the epidemiology of and interventions for outbreak control and antimicrobial stewardship. He provides undergraduate and post graduate education across a range of degree courses, is an examiner for the Royal College of Pathologists, and is Training Lead for infectious diseases, microbiology, and virology in West London. He is an associate editor for two journals and is a trustee for the UK Healthcare Infection Society.
Areas of interest
Drug-resistant infections; post-surgery infections; urinary tract infections; prostatitis; pneumonia; bone and joint infections; skin & soft tissue infections; COVID-19; Tropical infections
Current NHS consultant posts held
Consultant Infectious Diseases, Microbiology, & Virology, Chelsea & Westminster NHS Foundation Trust
Consultant Medical Microbiology, North West London Pathology, Imperial College Healthcare NHS Trust
Honorary Clinical Senior Lecturer, Imperial College London
Current research grants:
Chief Investigator (UK)/Principal Investigator (site): Retrospective Cefiderocol Study (PROVE).
Chief Investigator: SARS-CoV-2 in older people (SCALPEL).
Principal Investigator (site): Genetics of mortality in critical care (GenOMICC).
Principal Investigator: COVID-19 diagnostics evaluation and impact analysis.
Principal Investigator: Chelsea infectious diseases research (CINDER).
Co-Investigator: Randomised controlled trial of early favipiravir in COVID-19. (PIONEER).
Principal Investigator (site): Clinical Characterisation of Severe Emerging Infection (ISARIC).
Principal Investigator: Panton-Valentine Leukocidin S. aureus community transmission.
Principal Investigator (site): Observational Zavicefta Phase IV study (EZTEAM).
Principal Investigator (site): COVID19 community transmission (REACT 2).
Principal Investigator: Fomite microbial transmission in burns theatres.
Co-Investigator: Molecular diagnostics for ventilator-associated pneumonia (INHALE).
Selected Papers: I have published over 120 peer reviewed papers, with a h-Index of 26. In addition I have published 3 books, chapters in 7 further books, and presented over 100 abstracts at international conferences. Selected manuscripts in the last 2 years:
Pallett SJC, Denny SJ, Patel A, Charani E, Mughal N, Stebbing J, Davies G, Moore LSP. Point of care serological assays for SARS-CoV-2 in a UK hospital population: potential for enhanced case finding.Nat Scientific Reports.2021;11(1):5860.
Moshe M, Daunt A, Flower B, et al. SARS-CoV-2 Lateral Flow Assays for possible use in national COVID-19 seroprevalence surveys (REACT2): a diagnostic accuracy study.BMJ.2021;372:n423.
Rawson TM, Moore LSP, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing.Clin Infect Dis.2020;71(9):2459-2468.
Gibani MM, Toumazou C, Sohbati M, et al. Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study.Lancet Microbe.2020;1(7):300-307.
Pallett SJC, Rayment M, Patel A, Fitzgerald-Smith SAM, Denny SJ, Charani E, Mai AL, Gilmour KC, Hatcher J, Scott C, Randell P, Mughal N, Jones R, Davies GWâ€ , Moore LSPâ€ . Point-of-care serological assays for delayed SARS-CoV-2 case identification among UK healthcare workers; a prospective multicentre cohort study.Lancet Resp Med.2020;8(9):885-894.
Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalised patients with COVID-19: A retrospective cohort study in a UK secondary care setting.Clin Microbiol Infect.2020;26(10):1395-9.
Patel A, Charani E, Ariyanayagam D, Abdulaal A, Denny SJ, Mughal N, Moore LSP. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.Clin Microbiol Infect.2020;26(9):1236-41.
Rawson TM, Ming D, Ahmad R, Moore LSP, Holmes AH. Antimicrobial use, drug-resistant infections & COVID-19.Nat Rev Microbiol.2020;18(8):409-410.
- Fellowship of the Royal College of Pathologists Royal College of Pathologists 2011
- Masters Public Health London School of Hygiene & Tropical Medicine 2012
- Specialty Certificate in Infectious Diseases Royal College of Physicians 2014
- PhD Clinical Microbiology Imperial College London 2016
- Diploma University Lecturing & Teaching Imperial College London 2020
- Fellowship of the Higher Education Academy Higher Education Academy 2017
- Bachelor of Medicine & Bachelor of Surgery University of Leeds 2003
- Membership of the Royal College of Physicians Royal College of Physicians 2007
- Diploma of Tropical Medicine & Hygiene London School of Hygiene & Tropical Medicine 2007
- Masters Clinical Microbiology Queen Mary, University of London 2010
Reference number 6073422
Details of entry to specialist register
- Infectious Diseases, Microbiology, & Virology , 2017
Affiliations / memberships
Associate Editor: Journal of Infection.
Associate Editor: Annals of Clinical Microbiology and Antimicrobials.
Examiner: Royal College of Pathologists. UK.
Committee Member, Trustee, & Media Spokesperson: Healthcare Infection Society. UK.
Committee Member & Hub Lead: Specialty Training Committee; Infectious Diseases & Microbiology. London
Post treatment communication